Market Research Logo

Oligonucleotide Synthesis Market by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) - Global Forecast to 2024

Oligonucleotide Synthesis Market by Product (Probe, Linkers, Adaptor, Drugs, Reagent, Equipment), Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Hospital, Pharmaceutical, Biotechnology) - Global Forecast to 2024

“Increasing R&D expenditure by pharmaceutical and biotechnology companies and the rising demand for synthesized oligos in molecular diagnostics & therapeutics are expected to drive the overall growth of the oligonucleotide synthesis market”
The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% during the forecast period. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. The increasing applications of oligos in nucleic acid array-based technologies, library preparation, NGS, genomics, nucleic acid-based detection, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology are also driving the growth of this market.

“Hospitals accounted for the largest share of the oligonucleotide synthesis market, by end user, in 2018”
Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and hospitals. Hospitals held the largest share of the market in 2018 due to the significant number of inpatient and outpatient visits in hospitals and the requirement of oligonucleotide drugs to cater to the demand of the patient pool suffering from diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and hepatic veno-occlusive disease.

“Synthesized oligos dominated the oligonucleotide synthesis market, by product, in 2018
Based on product, the market is segmented into synthesized oligos, reagents, and equipment. The synthesized oligos segment held the largest share of the market in 2018 and is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the increasing applications of synthesized oligos in therapeutics, research, and diagnostics.

“North America to dominate the market during the forecast period”
Geographically, the oligonucleotide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America was the largest regional market for oligonucleotide synthesis. The North American market is also estimated to grow at the highest CAGR during the forecast period owing to the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the North American region.

The primary interviews conducted for this report can be categorized as follows:
By Company Type - Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
By Designation - C-level: 45%, D-level: 35%, and Others: 20%
By Region - North America: 45%, Europe: 25%, Asia Pacific: 18%, Latin America: 7%, and Middle East and Africa: 3%

List of Companies Profiled in the Report
include Agilent Technologies, Inc. (US)
ATDBio Ltd. (UK)
Bio-Synthesis, Inc. (US)
BioAutomation Corporation (US)
LGC Biosearch Technologies (US)
Eurofins Genomics (Germany)
Eurogentec (Belgium)
GeneDesign, Inc. (Japan)
GE Healthcare (US)
GenScript, Inc. (US)
Integrated DNA Technologies (IDT, US)
Nitto Denko Avecia, Inc. (US)
Sarepta Therapeutics (US)
Thermo Fisher Scientific, Inc. (US)
TriLink BioTechnologies (US)
Sigma-Aldrich Corporation (US) (a part of Merck KGAA)

Research Coverage:
This report provides a detailed picture of the global oligonucleotide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such as product & type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall oligonucleotide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • SECONDARY DATA
      • SECONDARY SOURCES
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
      • MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
      • MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • ATTRACTIVE OPPORTUNITIES IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET
    • SYNTHESIZED OLIGOS MARKET, BY PRODUCT
    • SYNTHESIZED OLIGOS MARKET, BY TYPE
    • ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY RESEARCH APPLICATION AND COUNTRY (2019)
    • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY THERAPEUTIC APPLICATION
    • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER
    • GEOGRAPHIC SNAPSHOT: OLIGONUCLEOTIDE SYNTHESIS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • MARKET DRIVERS
        • Table FDA-APPROVED OLIGONUCLEOTIDE-BASED THERAPIES
      • MARKET RESTRAINTS
      • MARKET OPPORTUNITIES
      • MARKET CHALLENGES
  • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT
    • INTRODUCTION
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
    • SYNTHESIZED OLIGOS
      • Table SYNTHESIZED OLIGOS MARKET, BY REGION, 2017-2024 (USD MILLION)
      • SYNTHESIZED OLIGOS MARKET, BY PRODUCT
        • Table SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table LATE-STAGE OLIGONUCLEOTIDE-BASED THERAPIES
        • Table OLIGONUCLEOTIDE-BASED DRUGS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table PRIMERS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table PROBES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIZED OLIGOS, BY REGION, 2017-2024 (USD MILLION)
        • Table LARGE-SCALE SYNTHESIZED OLIGOS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table LINKERS & ADAPTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
      • SYNTHESIZED OLIGOS MARKET, BY TYPE
        • Table SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table PREDESIGNED OLIGOS MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table CUSTOM OLIGOS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • REAGENTS
      • Table OLIGONUCLEOTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • EQUIPMENT
      • Table OLIGONUCLEOTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2017-2024 (USD MILLION)
  • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
    • THERAPEUTIC APPLICATIONS
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
      • DNA & ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES
        • Table ANTISENSE OLIGONUCLEOTIDES IN CLINICAL TRIALS
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA & ANTISENSE OLIGONUCLEOTIDEBASED THERAPIES, BY REGION, 2017-2024 (USD MILLION)
      • RNAI OLIGONUCLEOTIDE-BASED THERAPIES
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2017-2024 (USD MILLION)
      • CPG OLIGONUCLEOTIDE-BASED THERAPIES
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CPG OLIGONUCLEOTIDE-BASED THERAPIES, BY REGION, 2017-2024 (USD MILLION)
    • DIAGNOSTIC APPLICATIONS
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
    • RESEARCH APPLICATIONS
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • PCR
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
      • QPCR
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
      • SEQUENCING
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
      • GENE SYNTHESIS
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
      • OTHER RESEARCH APPLICATIONS
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER
    • INTRODUCTION
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • HOSPITALS
      • HOSPITALS ARE THE LARGEST END USERS OF OLIGOS DUE TO THE SIGNIFICANT NUMBER OF INPATIENT AND OUTPATIENT VISITS
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
    • ACADEMIC RESEARCH INSTITUTES
      • ACADEMIC RESEARCHERS PRIMARILY USE OLIGOS FOR GENETIC ENGINEERING, PCR ACTIVITIES, AND HIGH-THROUGHPUT SEQUENCING-A MAJOR FACTOR DRIVING MARKET GROWTH
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • GROWING APPLICATIONS OF OLIGOS IN DRUG DISCOVERY & THERAPEUTICS TO DRIVE THE DEMAND FOR OLIGONUCLEOTIDE SYNTHESIS AMONG THESE END USERS
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
    • DIAGNOSTIC LABORATORIES
      • DIAGNOSTIC LABORATORIES REGISTER HIGH GROWTH IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET DUE TO THE INCREASING SIGNIFICANCE OF OLIGOS IN MOLECULAR DIAGNOSTICS
        • Table OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
  • OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION
    • INTRODUCTION
      • Table OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • US
        • Table US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table US: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table US: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CANADA
        • Table CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table CANADA: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table CANADA: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • EUROPE
      • Table EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table EUROPE: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table EUROPE: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
      • Table EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • GERMANY
        • Table GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table GERMANY: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table GERMANY: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • FRANCE
        • Table FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table FRANCE: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table FRANCE: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • UK
        • Table UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table UK: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table UK: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • ITALY
        • Table ITALY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ITALY: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ITALY: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table ITALY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • SPAIN
        • Table SPAIN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table SPAIN: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table SPAIN: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table SPAIN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • ROE
        • Table ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROE: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROE: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table APAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table APAC: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table APAC: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table APAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
      • Table APAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table APAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table APAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CHINA
        • Table CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table CHINA: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table CHINA: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • JAPAN
        • Table JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table JAPAN: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table JAPAN: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • INDIA
        • Table INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table INDIA: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table INDIA: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • ROAPAC
        • Table ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROAPAC: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROAPAC: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • LATIN AMERICA
      • Table LATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table LATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table LATAM: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table LATAM: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
      • Table LATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table LATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • BRAZIL
        • Table BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • MEXICO
        • Table MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
      • ROLATAM
        • Table ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
        • Table ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
        • Table ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • Table MEA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table MEA: SYNTHESIZED OLIGOS MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
      • Table MEA: SYNTHESIZED OLIGOS MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table MEA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
      • Table MEA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table MEA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2017-2024 (USD MILLION)
      • Table MEA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET SHARE ANALYSIS
    • COMPETITIVE SCENARIO
      • PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS
      • PRODUCT LAUNCHES, UPGRADES, AND APPROVALS
      • EXPANSIONS
      • ACQUISITIONS
    • COMPETITIVE LEADERSHIP MAPPING (2017)
      • VANGUARDS
      • INNOVATORS
      • DYNAMIC PLAYERS
      • EMERGING PLAYERS
    • COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2018)
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: OLIGONUCLEOTIDE SYNTHESIS MARKET
  • COMPANY PROFILES
    • AGILENT TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ADTBIO
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
    • BIOAUTOMATION (ACQUIRED BY LGC)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-SYNTHESIS INC.
      • BUSINESS OVERVIEW
      • PRODUCTS/SERVICES OFFERED
    • EUROFINS GENOMICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • EUROGENTEC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GE HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GENSCRIPT
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • GENEDESIGN (PART OF AJINOMOTO)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • INTEGRATED DNA TECHNOLOGIES (ACQUIRED BY DANAHER CORPORATION)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LGC BIOSEARCH TECHNOLOGIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • MERCK KGAA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • NITTO DENKO AVECIA
      • BUSINESS OVERVIEW
      • SERVICES OFFERED
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • TRILINK BIOTECHNOLOGIES (PART OF MARAVAI LIFESCIENCES)
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report